Le Lézard
Classified in: Health
Subject: PDT

RareChannels.com Announces Disruptive Website Launch


MOUNT VERNON, Ill., July 17, 2018 /PRNewswire/ -- Carol J. Dickerson, Pharm D, Founder & CEO of Rare Channel Solutions, LLC announced the official launch of www.RareChannels.com, a new unaffiliated web-based resource that connects rare disease manufacturers and their affiliates to experienced and qualified solution partners.

RareChannelstm is a powerful, autonomous marketing partner for rare disease solution partners that are considered Partners in Raretm (PIRs).  PIRs are featured on RareChannels.com through company specific profile pages that highlight their services and/or products. Each PIR also has a secure contact form that allows site visitors to reach out to the PIR directly.

While working for a rare disease manufacturer, Carol noticed that finding experts equipped to handle the unique situations within rare disease was frustrating and time-consuming.  She knew bringing rare disease products to market could be done more efficiently, cheaper, and faster. 

As she explained, "When I began consulting on my own, I had no easy or cost-effective way to market my existence or niche-experience. There was a large gap in marketing channels connecting these morphing targets. The solution evolved into a very clear vision."

It was then that Carol realized she could empower rare manufacturers, by building an online reference to streamline the process of finding custom solutions.  So, she carefully designed RareChannels.com, to disrupt the market and fill the void in rare disease consulting. "We will continue expanding with other valuable resources, like a downloadable-slide library for hot-topics, a global rare conference/event calendar, and a vetting program," she said.    

Donovan Quill, President & CEO, Optime Care, noted:
"Connecting this way to the manufacturers in order to create awareness around our specialty distribution and high touch patient care models, specifically focused on small patient populations, made a whole lot of sense."

About RareChannels.com
RareChannelstm is a powerful, autonomous marketing partner for rare disease solution partners that are termed Partners in Raretm (PIRs).  PIRs are featured on RareChannels.com through company specific profile pages that highlight their services and/or products. Each PIR also has a secure contact form that allows site visitors to reach out directly.  PIR benefits also include social media boosts, and speaking opportunities and marketing material distribution at relevant conferences. Searchable main categories include: manufacturing, gene & cell therapy, research & development, data management, commercialization, marketing, market access strategy consulting, dispensing & administration networks, to name a few.

At launch, Rare Channels is proud to announce the following PIRs: Accredo, Option Care, CuraScriptSD, ValueCentric, Kendall Life Sciences, LLC, Viking Healthcare Solutions, Optime Care, World Congress/Integrate 2018 and The Kendall Law Firm PC.

For more information on Rare Channel Solutions, LLC or to become a Partner In Rare, please visit http://www.RareChannels.com or contact [email protected]

 

SOURCE Rare Channel Solutions, LLC


These press releases may also interest you

at 03:00
Todd Britten, DMD, a board-certified periodontist and dental implant specialist in...

at 03:00
SK chemicals (CEO Ahn Jae-hyun), Dongsung Chemical (Co-CEOs Baek Jin-woo and Lee Man-woo), and BYN Black Yak (Chairman Kang Tae-sun, hereinafter Black Yak) announced on the 18th that they've developed sustainable footwear materials using the...

at 02:55
First quarter  Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.Sales per region, in local currencies was +19% in APAC, -2% in EMEA and -14% in Americas.Sales per business area, in local currencies was...

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...



News published on and distributed by: